Latest filing published 03 Sept 2021 for Galera Therapeutics, Inc., €98k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jon T. Holmlund: trading record in brief
Jon T. Holmlund (senior executive) discloses dealings in Galera Therapeutics, Inc. to SEC (Form 4). We count 27 filings; the first trade dates from 5 May 2020 and the latest from 1 September 2021.
Every open-market trade on record is a sale: 13 sales worth €649k. Other entries cover 14 option exercises. 2021 to date brings no purchases and 1 sale.
Most recently, on 3 September 2021, the filings show an open-market sale worth €342k in Galera Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jon T. Holmlund
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 47,756 shares@ US$2.43100.0% of flowCommon StockSEC:0000899243-21-035130:0
1 of 1 declaration
